Succinylcholine

Succinylcholine: Overview

Succinylcholine is an ultra-short-acting depolarizing skeletal muscle relaxant used widely in surgical and emergency medical settings. It facilitates rapid endotracheal intubation and provides temporary muscle paralysis during general anesthesia and mechanical ventilation.

What Is Succinylcholine & How Does It Work?

Succinylcholine consists of two acetylcholine molecules joined together, functioning as a depolarizing neuromuscular blocker. Upon intravenous administration, it binds directly to nicotinic acetylcholine receptors located on the post-synaptic motor endplate of muscle cells. This binding causes persistent electrical depolarization of the muscle membrane, initially seen as brief, visible muscle twitching known as fasciculations. Because Succinylcholine degrades more slowly than endogenous acetylcholine, the motor endplate remains depolarized and unresponsive to subsequent nerve signals, resulting in rapid and complete skeletal muscle paralysis.

Is Succinylcholine FDA Approved?

Succinylcholine received official prescription approval from the United States Food and Drug Administration in August 1952 under trade names including Anectine and Quelicin. In a General Medicine, emergency, and surgical department setting, anesthesiologists and critical care specialists utilize Succinylcholine to manage airway emergencies and maintain muscle relaxation.

What Is Succinylcholine Used For?

• Facilitating rapid sequence endotracheal intubation during emergency airway management and surgical procedures.
• Providing short-term skeletal muscle relaxation during general anesthesia and surgical operations.
• Suppressing spontaneous muscle movements during brief diagnostic procedures or mechanical ventilation.

Before Taking Succinylcholine: Contraindications & Precautions

Because Succinylcholine causes rapid shifts in intracellular potassium, thorough patient screening before administration is mandatory in clinical practice.

Who Should Not Take Succinylcholine?

Succinylcholine is strictly contraindicated in patients with a personal or family history of malignant hyperthermia or known skeletal muscle myopathies like Duchenne muscular dystrophy. It must never be administered to patients in the acute phase of major burns, severe trauma, massive denervation injuries, or upper motor neuron lesions due to severe hyperkalemia risks. Patients with known hypersensitivity to Succinylcholine chloride or plasma cholinesterase deficiency should also avoid this drug.

Succinylcholine: Pregnancy & Fertility

Succinylcholine does not cross the placental barrier in significant amounts under normal clinical doses, making it a standard choice during emergency cesarean sections. It should be used during pregnancy only when clearly needed, as plasma cholinesterase levels are decreased in pregnant women, potentially prolonging paralysis. Trace amounts excreted in human milk are negligible, and animal studies demonstrate no direct impairment of reproductive fertility.

Tell Your Doctor Before Taking Succinylcholine

Inform your anesthesiologist if you or any family members have ever experienced severe fever or complications under general anesthesia. Disclose any recent severe burns, extensive crush injuries, nerve damage, or chronic muscle weakness. List all current medications, including glaucoma eye drops, cardiac drugs, and herbal supplements.

Succinylcholine: Dosage & Administration

Succinylcholine is administered intravenously or intramuscularly exclusively by trained healthcare professionals equipped with full airway support equipment.

• Intravenous Solution: Administered as a rapid bolus injection or continuous infusion for controlled muscle relaxation.
• Intramuscular Solution: Used primarily in pediatric emergencies when intravenous access is unavailable.
• Administration Setting: Strictly restricted to operating rooms, intensive care units, and emergency departments.

Standard Succinylcholine Dosing

For standard adult endotracheal intubation, the typical intravenous dose of Succinylcholine ranges from 0.6 mg/kg to 1.1 mg/kg given as a single rapid bolus over 10 to 30 seconds. Onset of full paralysis occurs within 30 to 60 seconds and lasts approximately 4 to 6 minutes. For prolonged surgical procedures, continuous intravenous infusions of a 0.1 percent to 0.2 percent solution may be titrated based on patient response.

How Succinylcholine Is Administered

Succinylcholine injection is inspected visually for clarity before manual administration through an established intravenous line. Intramuscular doses up to 3 mg/kg to 4 mg/kg may be injected into deep muscle tissue if intravenous access cannot be established quickly.

Succinylcholine: Clinical Efficacy & Research

Clinical consensus confirms that Succinylcholine remains the gold standard for rapid sequence intubation due to its unparalleled speed of onset and short duration of action. Clinical trials demonstrate that Succinylcholine reliably produces optimal intubation conditions within 60 seconds in over ninety percent of patients. Research shows that its rapid spontaneous recovery, mediated by plasma pseudocholinesterase hydrolysis within 10 minutes, provides an unmatched safety margin during difficult or unexpected airway scenarios.

Succinylcholine: Side Effects & Safety Profile

While highly effective, Succinylcholine exhibits a complex safety profile involving autonomic, cardiac, and metabolic systems.

Common Succinylcholine Side Effects

• Postoperative muscle soreness, stiffness, and transient fasciculations
• Mild increases in intraocular, intragastric, and intracranial pressure
• Excessive salivation and transient skin flushing
• Mild heart rate changes, including transient sinus bradycardia or tachycardia

Serious Succinylcholine Adverse Events

• Malignant hyperthermia, characterized by rapid temperature rise, severe muscle rigidity, and metabolic acidosis
• Severe, life-threatening hyperkalemia leading to cardiac arrest, particularly in denervated or burned patients
• Prolonged neuromuscular paralysis and apnea in individuals with plasma cholinesterase deficiency
• Severe anaphylactic reactions and profound bronchial spasms

Managing Succinylcholine Side Effects

If malignant hyperthermia triggers, administration of Succinylcholine must be stopped immediately, and intravenous dantrolene sodium combined with active body cooling initiated. If hyperkalemic cardiac arrest occurs, aggressive resuscitation, intravenous calcium chloride, bicarbonate, and insulin-glucose therapy are administered immediately.

Succinylcholine: Interactions & What to Avoid

Co-administering Succinylcholine with medications that alter cholinesterase activity or neuromuscular transmission requires extreme caution.

Succinylcholine: Interactions

• Cholinesterase inhibitors (neostigmine, pyridostigmine, organophosphates): Prolong Succinylcholine paralysis by inhibiting its breakdown by plasma cholinesterase.
• Inhalational anesthetics (isoflurane, sevoflurane): Significantly increase the risk of triggering malignant hyperthermia and enhance muscle relaxation.
• Cardiac glycosides (digoxin): Concurrent exposure heightens the risk of severe cardiac arrhythmias secondary to rapid potassium release.

Succinylcholine: Food & Alcohol

Dietary intake does not directly alter intravenous Succinylcholine administration, though patients undergoing general anesthesia must follow strict fasting protocols to prevent aspiration. Alcohol consumption can potentiate central nervous system depression and alter baseline cardiac stability during anesthesia.

Succinylcholine: Missed Dose, Overdose & Storage

Because Succinylcholine is administered solely during controlled clinical procedures, routine patient self-administration guidelines do not apply.

Missed Dose of Succinylcholine

Missed dose scenarios do not occur, as Succinylcholine is administered on-demand as a single procedure-specific bolus by healthcare providers.

Succinylcholine: Overdose & Emergency

Succinylcholine overdose results in prolonged muscle paralysis, apnea, and prolonged respiratory muscle weakness. Emergency treatment requires continuous mechanical ventilation and airway maintenance until spontaneous plasma cholinesterase metabolism restores native muscle function.

How To Store Succinylcholine

Store Succinylcholine injection solutions under refrigeration between 2°C and 8°C (36°F and 46°F) in their original packaging. Unrefrigerated storage at room temperature up to 25°C (77°F) is permitted for up to 14 days, after which unused portions must be discarded.

Succinylcholine: Patient Management & Monitoring

Continuous electrophysiological and vital sign monitoring is mandatory whenever Succinylcholine is administered.

Tests Before Starting Succinylcholine

• Assessment of serum potassium levels, especially in patients with renal failure, recent trauma, or severe burns.
• Pre-anesthetic screening for personal or family histories of malignant hyperthermia, muscle weakness, or pseudocholinesterase deficiency.

Monitoring During Succinylcholine Treatment

• Continuous electrocardiographic (ECG) monitoring, blood pressure measurement, and pulse oximetry.
• End-tidal carbon dioxide and core body temperature monitoring to detect early signs of malignant hyperthermia.

Succinylcholine: Do’s and Don’ts

• Do ensure an advance airway and continuous mechanical ventilation equipment are fully operational before administration.
• Do keep intravenous dantrolene readily accessible whenever Succinylcholine is used alongside inhalational anesthetics.
• Don’t administer Succinylcholine to patients with chronic denervation injuries or major burn recovery.
• Don’t attempt to reverse Succinylcholine paralysis with neostigmine, as this worsens neuromuscular blockade.

Frequently Asked Questions

References

• United States Food and Drug Administration. Anectine and Quelicin (Succinylcholine Chloride) Prescribing Information.
• DrugBank Online Database. Succinylcholine Compound Summary (Accession Number DB00202).
• World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index: M03AB01 (Suxamethonium).

Legal Disclaimer

The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.